Stock Price
543.01
Daily Change
0.65 0.12%
Monthly
-12.01%
Yearly
-4.98%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $35.68B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.41B 640M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Boston Scientific USD 12.05B 19M Sep/2025
Bruker USD 2.44B 321.5M Jun/2025
Charles River Laboratories USD 2.79B 74.83M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Dentsply International USD 2.49B 159M Jun/2025
Edwards Lifesciences USD 702.6M 3.2M Jun/2025
Exact Sciences USD 2.34B 15.24M Sep/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Henry Schein USD 3.36B 2.21B Jun/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratory Of America USD 6.55B 26.4M Jun/2025
Medtronic USD 28.61B 93M Jun/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Olympus JPY 229.1B 4.23B Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.37B 5.86M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Veracyte USD 50.65M 145K Jun/2025
Waters USD 1.54B 36.51M Jun/2025
Zimmer Biomet Holdings USD 8.11B 540.1M Sep/2025